Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a new post hoc analysis of aspirin use in REDUCE-IT® reinforcing that ...

GoodRx Holdings (GDRX) shares have slipped about 27% over the past month, drawing investor attention to recent performance trends. The company’s ongoing path sparks questions about how current ...

Value-based care and early palliative care are strategies to mitigate rising cancer treatment costs due to longer patient ...

In July 2025, the FDA approved Longeveron’s Investigational New Drug (IND) application for its stem cell therapy laromestrocel as a potential treatment for pediatric dilated cardiomyopathy (DCM). The ...